Colorectal Cancer Drugs Market Overview, Trends, Growth, Demand, Key Players Analysis And Forecast To 2031
The global colorectal cancer drugs market report by the business research company identifies the increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body's immune system to fight cancer rather than chemical drugs which reduces the body's immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective.
The global colorectal cancer drugs market grew from $12.75 billion in 2021 to $13.71 billion in 2022 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The colorectal cancer drugs market is expected to grow to $16.01 billion in 2026 at a CAGR of 3.9%.
Purchase The Colorectal cancer drugs Market Report Here:
North America was the largest region in the colorectal cancer drugs market in 2021. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the colorectal cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Major players in the colorectal cancer drugs market are Merck & Co. Inc, Roche, Sanofi, Amgen, Pfizer Inc., Abbott Laboratories, Taiho Pharma, Novartis, GlaxoSmithKline, Onyx, TAKEDA PHARMACEUTICALS, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Eli Lilly, RANDOX LABORATORIES, Suzhou Zelgen Biopharmaceuticals, Beckman Coulter Inc, Regeneron, EDP Biotech, Genomic Tree, Metabiomics Corporation, SIEMENS HEALTHCARE, Suzhou Zelgen Biopharmaceuticals, Sumitomo Dainippon Pharma and EPIGENOMICS.
The global colorectal cancer drugs market is segmented -
1) By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators
2) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Others
3) By Class: Immunotherapy, Chemotherapy, Others
Request A Sample Of The Colorectal cancer drugs Market Report Here:
The Colorectal cancer drugs Market Report Contents Include
1. Executive Summary
2. Colorectal Cancer Drugs Market Characteristics
3. Colorectal Cancer Drugs Market Trends And Strategies
4. Colorectal Cancer Drugs Market - Macro Economic Scenario
5. Colorectal Cancer Drugs Market Size And Growth
26. Africa Colorectal Cancer Drugs Market
27. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles
28. Colorectal Cancer Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market
30. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
TBRC Blog: http://blog.tbrc.info/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/
This report covers the trends and market dynamics of the colorectal cancer drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Drugs Market Overview, Trends, Growth, Demand, Key Players Analysis And Forecast To 2031 here
News-ID: 2821281 • Views: 187
More Releases from The Business research company
Vertical - Specific Software Market Insights, Trends, Segments And Global Foreca …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the vertical - specific software minerals market report by The Business Research Company, The adoption of 5G technology is expected to propel the growth of the vertical-specific software market going forward. 5G is the fifth generation of mobile networks that enables a new type
Therapeutic Nutrients And Minerals Market Trends, Growth, Major Players Analysis …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the therapeutic nutrients and minerals market report by The Business Research Company, The rising demand for immunity-boosting products is expected to propel the growth of the therapeutic nutrients and minerals market going forward. Immunity-boosting products are dietary supplements, foods, or beverages that improve or
Networking Support Services Market Trends, Top Companies, Share, Growth And Fore …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Networking Support Services Market Size, Growth Rate, And Forecast The global networking support services market size is expected to grow from $838.14 billion in 2022 to $886.56 billion in 2023 at a compound annual growth rate (CAGR) of 5.8%. The Russia-Ukraine war disrupted the chances of global
Household Natural Gas Distribution Market
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Household Natural Gas Distribution Market Size, Growth Rate, And Forecast The global household natural gas distribution market size is expected to grow from $169.49 billion in 2022 to $179.20 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances
More Releases for Colorectal
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
In-vitro Colorectal Cancer Screening Tests Market to Reach US$980.6 mn by 2023, …
A research report on the global in-vitro colorectal cancer screening tests market for by Transparency Market Research (TMR) estimates this market to expand at a CAGR of 7.50% during the period from 2015 and 2023. In 2014, the market stood at US$494.1 mn and it is projected reach a value of US$980.6 mn by the end of the forecast period.The research report is titled “In-vitro Colorectal Cancer Screening Tests Market
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which